98%
921
2 minutes
20
Purpose: Getting an incurable oesophageal or gastric cancer diagnosis is a major stressful life event associated with severe physical, psychosocial and existential challenges. To provide timely and efficient support, based on patients' experiences, the aim of the study was to explore how patients newly diagnosed with incurable oesophageal and gastric cancer manage everyday life.
Method: Semi-structured interviews were conducted with 12 patients 1-3 months after being diagnosed with incurable oesophageal or gastric cancer. Four participants were interviewed twice, which resulted in 16 interviews. Data were analysed with qualitative content analysis.
Results: An overall theme, "Striving towards normality in an unpredictable situation", with three related themes - "Trying to comprehend the disease", "Dealing with the consequences of illness" and "Re-evaluating what is important in everyday life" - and seven sub-themes were identified. The participants described an unexpected and unpredictable situation, in which they strived to maintain their normal life. Amidst struggling to manage problems related to eating, fatigue and an incurable diagnosis the participants talked about the importance of focusing on the positive and normal aspects of life.
Conclusions: The findings in this study point to the importance of supporting patients' confidence and skills, particularly with regard to managing eating, so that they can hold on to their normal life as much as possible. The findings further point to the possible benefit of integrating an early palliative care approach and could provide guidance for nurses and other professionals on how to support patients post diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejon.2023.102302 | DOI Listing |
BMJ Open
August 2025
Department of General Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Objectives: Oesophago-gastric cancer is one of the most common causes of cancer death worldwide. Care pathways are highly variable and complex to organise;however,there is limited evidence from a service user perspective to inform service design for best experience of care. This study explored the experiences of people living with incurable oesophago-gastric cancer to determine how services can be delivered to best support their needs.
View Article and Find Full Text PDFMolecules
June 2025
School of Physics and Laboratory of Zhongyuan Light, Zhengzhou University, Zhengzhou 450001, China.
(1) Objective: Cold atmospheric plasma (CAP) is a safe and effective alternative to radiotherapy for cancer treatment. Its anticancer effects are attributed to increased intracellular reactive oxygen species (ROS). Glutathione, a key antioxidant derived from glutamine, is critical for cell proliferation.
View Article and Find Full Text PDFBest Pract Res Clin Gastroenterol
March 2025
Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address:
The incidence of oesophageal squamous cell carcinoma accounts for almost 85 % of all oesophageal cancers worldwide. Patients with oesophageal cancer can present with clinical symptoms including dysphagia, weight loss, retrosternal discomfort or regurgitation. Nevertheless, most cancers remain asymptomatic and thereby undetected until the cancer has reached advanced or even incurable stages.
View Article and Find Full Text PDFJ Gastrointest Cancer
April 2025
Department of Radiation Oncology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Purpose: Self-expandable metallic stents (SEMS) provide immediate but nondurable dysphagia relief in esophageal cancer, while external beam radiotherapy (EBRT) provides slower, more durable dysphagia relief. While the combination of SEMS with EBRT would seem to offer both rapid and durable dysphagia relief in the palliative setting, there remains controversy on its safety and efficacy. We investigated patient outcomes regarding EBRT after SEMS placement in patients with incurable esophageal cancer at a regional Canadian cancer program.
View Article and Find Full Text PDFCureus
February 2025
Hospital Medicine, Russell Medical Center, Alexander City, USA.
Metastasis is one of the most significant contributors to mortality and treatment-related morbidity in patients with advanced-stage lung cancer, as it is often considered incurable once discovered. Accordingly, a significant challenge with metastasis is identifying its progression early, as initial imaging may be negative while metastasis propagates undetected. Hence, there is a growing consensus that determining the optimal frequency and improving screening protocols for brain metastasis in patients with lung cancer are essential areas of research, as earlier detection could allow for prompt adjustments in treatment and/or prophylactic interventions, thereby potentially improving outcomes and reducing risks associated with more invasive procedures.
View Article and Find Full Text PDF